| Literature DB >> 27096319 |
Thomas Blank1, Claudia N Detje2, Alena Spieß1, Nora Hagemeyer1, Stefanie M Brendecke1, Jakob Wolfart3, Ori Staszewski1, Tanja Zöller1, Ismini Papageorgiou4, Justus Schneider4, Ricardo Paricio-Montesinos1, Ulrich L M Eisel5, Denise Manahan-Vaughan6, Stephan Jansen6, Stefan Lienenklaus7, Bao Lu8, Yumiko Imai9, Marcus Müller10, Susan E Goelz11, Darren P Baker12, Markus Schwaninger13, Oliver Kann4, Mathias Heikenwalder14, Ulrich Kalinke2, Marco Prinz15.
Abstract
Sickness behavior and cognitive dysfunction occur frequently by unknown mechanisms in virus-infected individuals with malignancies treated with type I interferons (IFNs) and in patients with autoimmune disorders. We found that during sickness behavior, single-stranded RNA viruses, double-stranded RNA ligands, and IFNs shared pathways involving engagement of melanoma differentiation-associated protein 5 (MDA5), retinoic acid-inducible gene 1 (RIG-I), and mitochondrial antiviral signaling protein (MAVS), and subsequently induced IFN responses specifically in brain endothelia and epithelia of mice. Behavioral alterations were specifically dependent on brain endothelial and epithelial IFN receptor chain 1 (IFNAR). Using gene profiling, we identified that the endothelia-derived chemokine ligand CXCL10 mediated behavioral changes through impairment of synaptic plasticity. These results identified brain endothelial and epithelial cells as natural gatekeepers for virus-induced sickness behavior, demonstrated tissue specific IFNAR engagement, and established the CXCL10-CXCR3 axis as target for the treatment of behavioral changes during virus infection and type I IFN therapy.Entities:
Keywords: CXCL10; CXCR3; IFN; IFNAR1; IPS-1; MAVS; behavior; brain; depression; endothelia; epithelia; influenza; neurons; signal transduction; type I interferon; virus infection
Mesh:
Substances:
Year: 2016 PMID: 27096319 DOI: 10.1016/j.immuni.2016.04.005
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745